- Home
- WU vs ITGR Comparison
WU vs ITGR Comparison
Compare WU & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WU | ITGR |
|---|---|---|
| Founded | 1851 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2006 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WU | ITGR |
|---|---|---|
| Price | $8.88 | $85.24 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $9.00 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 6.9M | 623.5K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 10.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.52 | ★ 2.89 |
| Revenue | ★ $4,050,700,000.00 | $1,853,637,000.00 |
| Revenue This Year | $8.57 | $1.69 |
| Revenue Next Year | $4.71 | $6.53 |
| P/E Ratio | ★ $5.92 | $30.01 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $7.85 | $62.00 |
| 52 Week High | $10.37 | $127.56 |
Technical Indicators
Market Signals| Indicator | WU | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 44.13 | 48.59 |
| Support Level | $7.96 | $82.58 |
| Resistance Level | $9.80 | $88.54 |
| Average True Range (ATR) | 0.25 | 2.13 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 48.99 | 29.81 |
Price Performance
Historical ComparisonAbout WU Western Union Company (The)
Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2025 and is the largest money transfer company in the world.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.